Skip to content
DataLookout
Menu

NCT07894640

Clinical Safety and Efficacy Evaluation of the Blood-cooling and Stasis-removing Formula as an Adjunct to Atorvastatin in the Treatment of Hemorrhagic Moyamoya Disease.

StatusEnrolling by Invitation
PhaseEarly Phase 1
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Percentage of Participants With an Increase of at Least 1 Point in Cerebral Perfusion Staging Score
Timeframe: Baseline (before intervention) and the day after completion of the 3-month treatment course

Secondary (7)

Fugl-Meyer Assessment of Motor Function Score
Modified Barthel Index Score
Montreal Cognitive Assessment Score
National Institutes of Health Stroke Scale Score
Incidence of New Intracerebral Hemorrhage
Show 2 moreShow less
Incidence of Recurrent or New Cerebral Infarction
All-Cause Mortality

Arms and interventions

Atorvastatin + Blood-cooling and Stasis-clearing FormulaExperimental

Based on standard Western medicine treatment (as placebo comparator), a modified version of the blood-cooling and stasis-removing formula (200ml per dose, twice a day, one dose each time, a formula agreed upon by Nanjing Municipal Hospital of Traditional Chinese Medicine)+Lipid-lowering drug (atorvastatin, Pfizer, 10mg, one tablet once a day) was used for treatment.

Atorvastatin + Blood-cooling and Stasis-clearing Formula PlaceboPlacebo comparator

Standard Western medical treatment was administered. Upon diagnosis, vital signs were immediately monitored, and imaging examinations including a head CT scan, complete blood count, comprehensive biochemistry panel, and coagulation function tests were completed. Routine Western medical intervention was given, including lipid-lowering drugs (atorvastatin, Pfizer, 10mg once daily, one tablet). A placebo was added accordingly. The placebo was prepared by mixing 10% of the original drug formula with rice and edible flavoring to create a control placebo with similar color, taste, and properties.

Drugs: Atorvastatin, Blood-cooling and Stasis-clearing Formula, Blood-cooling and Stasis-clearing Formula Placebo

Sites

1 site in 1 country

  • Jiangsu Province Hospital (Jiangsu Provincial People's Hospital)Nanjing, Jiangsu, China